1. Home
  2. BNZI vs VRAX Comparison

BNZI vs VRAX Comparison

Compare BNZI & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$0.56

Market Cap

12.8M

Sector

N/A

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.13

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
VRAX
Founded
2016
2013
Country
United States
United Kingdom
Employees
34
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
1.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BNZI
VRAX
Price
$0.56
$0.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$24.00
$1.00
AVG Volume (30 Days)
810.9K
18.9M
Earning Date
05-14-2026
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.28
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$0.10
52 Week High
$4.44
$1.18

Technical Indicators

Market Signals
Indicator
BNZI
VRAX
Relative Strength Index (RSI) 33.13 40.51
Support Level $0.53 $0.10
Resistance Level $0.76 $0.26
Average True Range (ATR) 0.08 0.03
MACD -0.00 0.00
Stochastic Oscillator 11.00 25.76

Price Performance

Historical Comparison
BNZI
VRAX

About BNZI Banzai International Inc.

Banzai International Inc is a Software as a Service (SaaS) company operating in the marketing technology (MarTech) industry. The group provides customers with tools to help them market and sell with greater efficiency and impact. Its customers include Amazon, Dell, Salesforce, Aflac, Thermo Fisher Scientific, RBC Wealth Management, Fitch Group, and many other brands. The Company has three reportable operating segments: Banzai Operating Co, Inc., OpenReel, and Vidello. Its segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions, including video production and editing, for businesses of all sizes. Geographically, it operates in the Americas, Europe, the Middle East and Africa (EMEA), and the Asia Pacific.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.

Share on Social Networks: